Expression of Fas/CD95 and Bcl-2 by primitive hematopoietic progenitors freshly isolated from human fetal liver

Blood

Volumn 88, Issue 6, 1996, Pages 2013-2025

  Bárcena, Alicia ^a   Park, Suk W ^b   Banapour, Babak ^b   Muench, Marcus O ^b   Mechetner, Eugene ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN; CYTOKINE; FAS ANTIGEN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; MONOCLONAL ANTIBODY; STEM CELL FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANTIBODY SPECIFICITY; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; COLONY FORMING UNIT C; FETUS; FETUS LIVER; FLOW CYTOMETRY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; PHENOTYPE; PRIORITY JOURNAL;

EID: 0029818857     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.6.2013.bloodjournal8862013     Document Type: Article

References (61)

1. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S-I, Sameshima M, Hase A, Seto Y. Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233, 1991
2. Watanabe-Fukunaga R, Brannan CI, Iloh N, Yonehara S, Copeland NG, Jenkins NA, Nagata S: The cDNA structure, expression and chromosomal assignment of the mouse Fas antigen. J Immunol 148:1274, 1992
3. Miyawaki T, Uehara T, Nibu R, Tsuji T, Yachie A. Yonehara S, Taniguchi N: Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J Immunol 149:3753, 1992
4. Robertson MJ, Manley TJ. Pichert G, Cameron C, Cochran KJ, Levine H, Ritz J: Functional consequences of Apo-I/Fas (CD95) antigen expression by normal and neoplastic hematopoietic cells. Leuk Lymphoma 17:51, 1995
5. Falk MH, Trauth BC, Debatin K-M, Klas C, Gregory CD, Rickinson AB, Calender A, Lenoir GM, Ellwart JW, Krammer PH, Bornkamm GW: Expression of the APO-1 antigen in Burkitt lymphoma cell lines correlates with a shift toward a lymphoblastoid phenotype. Blood 79:3300, 1992
6. Debatin K-M, Goldman CK, Waldman TA, Krammer PH: APO-1-induced apoptosis of leukemia cells from patients with adult T-cell leukemia. Blood 81:2972, 1993
7. Owen-Shaub LB, Radinsky R, Kruzel E, Berry K, Yonehara S: Anti-Fas on non-hematopoietic tumors: Levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness. Cancer Res 54:1580, 1994
8. Weller M, Frei K, Groscurth P, Krammer PH, Yonekawa Y, Fontana A: Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines. J Clin Invest 94:954, 1994
9. Suda T, Takahashi T, Golstein P, Nagata S: Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169, 1993
10. Dhein J, Walczak H, Bäumler C, Debatin K-M, Krammer PH: Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373:438, 1995
11. Brunner T, Mogli RJ, LaFace D, Yoo NJ, Mahbouli A, Echeverri F, Martin SJ, Force WR, Lynch DH, Ware CF, Green DR: Cell-autonomous Fas (CD95)/Fas ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373:441, 1995
12. Itoh N, Tsujimoto Y, Nagata S: Effect of bcl-2 on Fas-mediated cell death. J Immunol 151:621, 1993
13. Kägi D, Vignaux F, Ledermann B, Burki K, Depraetere V, Nagata S, Hengartner H, Golstein P: Fas and perforin pathways as major mechanisms of T-cell-mediated cytotoxicity. Science 265:528, 1994
14. Alderson MR, Tough TW, Davis-Smith T, Braddy S, Falk B, Schooley KA, Goodwin RG, Smith CA, Ramsdell F, Lynch DH: Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med 181:71, 1995
15. Alderson MR, Armitage RJ, Maraskovsky E, Tough TW, Roux E, Schooley K, Ramsdell F, Lynch DH: Fas transduces activation signals in normal human T lymphocytes. J Exp Med 178:2231, 1993
16. Mapara MY, Bargou R, Zugck C, Döhner H, Ustaoglu F, Jonker RR, Krammer P, Dörken B: APO-1 mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: Correlation with bcl-2 oncogene expression. Eur J Immunol 23:702, 1993
17. Owen-Sehaub LB, Yonehara S, Crump WL III, Grimm EA: DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell Immunol 140:197, 1992
18. Klas C, Debatin K-M, Jonker RR, Krammer PH: Activation interferes with the APO-1 pathway in mature human T cells. Int Immunol 5:625, 1993
19. Wong GHW, Goeddel DV: Fas antigen and p55 TNF receptor signal apoptosis through distinct pathways. J Immunol 152:1751, 1994
20. Tsujimoto Y, Finger LR, Yunis J, Nowell PC, Croce CM: Cloning the chromosome breakpoint of neoplastic B-cells with the t(14;18) chromosome translocation. Science 226:1097, 1984
21. Bakhshi A, Jensen JP, Goldman P, Wright J, McBride OW, Epstein AL, Korsmeyer SJ: Cloning the chromosomal breakpoint of t(14;18) human lymphomas: Clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell 41:899, 1985
22. Nuñez G, London L, Hockenbery D, Alexander M, McKearn JP, Korsmeyer SJ: Deregulated bcl-2 gene expression selectively prolongs survival of growth factor-deprived hematotopoietic cell lines. J Immunol 144:3602, 1990
23. Korsmeyer SJ: Regulators of cell death. Trends Genet 11:101, 1995
24. Clark SC, Kamen R: The human hematopoietic colony-stimulating factors. Science 236:1229, 1987
25. Mizel SB: The interleukins. FASEB J 3:2379, 1989
26. Moore MAS: Clinical implications of positive and negative hematopoietic stem cell regulators. Blood 78:1, 1991
27. Bárcena A, Galy AHM, Punnonen J. Muench MO, Schols D. Roncarolo M-G, De Vries JE: Lymphoid and myeloid differentiation of fetal liver CD34+lineage - cells in human thymic organ culture. J Exp Med 180:123, 1994
28. Koury MJ: Programmed cell death (apoptosis) in hematopoiesis. Exp Hematol 20:391, 1992
29. Koury MJ, Bondurant MC: Erythropoietin retards DNA breakdown and prevents programed cell death in erythroid progenitor cells. Science 248:378, 1990
30. Rodriguez-Tarduchy G, Collins M, Lopez-Rivas A: Regulation of apoptosis in interleukin-3 dependent hematopoietic cells by interleukin-3 and calcium ionophore. EMBO J 9:2997, 1990
31. Bazil V. Brandt J, Tsukamoto A, Hoffman R: Apoptosis of human hematopoietic progenitor cells induced by cross-linking of surface CD43, the major sialoglycoprotein of leukocytes. Blood 86:502, 1995
32. + human marrow cells is induced by Interferon y and tumor necrosis α and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood 85:3183, 1995
33. Nagafuji K, Shibuya T, Harada M, Mizuno S-I, Tanenaka K, Miyamoto, T., Okamura T, Gondo H, Niho Y: Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells. Blood 86:883, 1995
34. Landsdorp PM, Dragowska W, Mayani H: Ontogeny-related changes in proliferative potential of human hematopoietic cells. J Exp Med 178:787, 1993
35. Cappellini MD, Potter CG, Wood WG: Long-term haemopoiesis in human fetal liver cell cultures. Br J Haematol 57:61, 1984
36. Bárcena A, Muench MO, Galy AHM, Cupp J, Roncarolo MG, Phillips JH, Spits H: Phenotypic and functional analysis of T-cell precursors in the human fetal liver and thymus. CD7 expression in the early stages of T- and myeloid-cell development. Blood 82:3401, 1993
37. Muench MO, Roncarolo MG, Menon S, Xu Y, Kastelein R, Zurawski S, Hannum CH, Culpepper J, Lee F, Namikawa R: FLK-2/FLT-3 ligand (FL) regulates the growth of early myeloid progenitors isolated from human fetal liver. Blood 85:963, 1995
38. Bradley TR, Hodgson GS: Detection of primitive macrophage progenitor cells in mouse bone marrow. Blood 54:1446, 1979
39. Ormerod MG, Collins MKL, Rodriguez-Tarduchy G, Robertson D: Apoptosis in interleukin-3-dependent haemopoietic cells. Quantitation by two flow cytometric methods. J Immunol Methods 153:57, 1992
40. Ormerod MG, Sun X-M, Brown D, Snowden RT, Cohen GM: Quantification of apoptosis and necrosis by flow cytometry. Acta Oncol 32:417, 1993
41. Esolen LM, Park SW, Hardwick JM, Griffin DE: Apoptosis as a cause of death in measles virus-infected cells. J Virol 69:3855, 1995
42. + human fetal liver progenitors with a high proliferative potential. Blood 83:3170, 1994
43. - progenitor cells. Blood 77:1218, 1991
44. - progenitor cells in long-term cultures and semisolid assays. Blood 81:2916, 1993
45. + bone marrow cells. Blood 84:1473, 1994
46. LeBien TW, McCormack RT: The common acute lymphoblastic leukemia antigen (CD10)-emancipation from a functional enigma. Blood 73:625, 1989
47. Craig W, Kay R, Cutler RL, Lansdorp PM: Expression of Thy-1 on human hematopoietic progenitor cells. J Exp Med 177:1331, 1993
48. Lansdorp PM, Sutherland HJ, Eaves CJ: Selective expression of CD45 isoforms on functional subpopulations of CD34+ hemopoietic cells from human bone marrow. J Exp Med 172:363, 1990
49. Papayannoppoulou T, Bricce M, Broudy VC, Zsebo KM: Isolation of c-kit receptor expressing cells from bone marrow, peripheral blood, and fetal liver: Functional properties and composite antigenic profile. Blood 78:1403, 1991
50. Yonehara S, Ishii A, Yonehara M: A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 169:1747, 1989
51. Rüsten LS, Smeland EB, Jacobsen FW, Lien E, Lesslauer W, Loetscher H, Dubois CM, Jacobsen SEW: Tumor necrosis factor-α inhibits stem cell factor-induced proliferation of human bone marrow progenitor cells in vitro. J Clin Invest 94:165, 1994
52. Zoumbos NC, Djeu JY, Young NS: Interferon is the suppresor of hematopoiesis generated by stimulated lymphocytes in vitro. J Immunol 133:769, 1984
53. Broxmeyer HE, Williams DE, Lu L. Cooper S, Anderson SL, Beyer GS, Hoffman R, Rubin BY: The suppresive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: Synergism of tumor necrosis factor and interferon-gamma. J Immunol 136:4487, 1986
54. Surh CD, Sprent J: T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature 372:100, 1994
55. Ogasawara J, SudaT, Nagata T: Selective apoplosis of CD4+ CD8+ thymocytes by the anti-Fas antibody. J Exp Med 181:485, 1995
56. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S: Lymphoproliferative disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314, 1992
57. Sidman CL, Marshall JD, von Boehmer H: Transgenic T cell receptor interactions in the lymphoproliferative and autoimmune syndromes of lpr and gld mutant mice. Eur J Immunol 22:499, 1992
58. Lanier LL, Recktenwald DJ: Multicolor immunofluorescence and flow cytometry. Methods Enzymol 2:192, 1991
59. Brach MA, deVos S, Gruss HJ, Hermann F: Prolongation of survival of human polymorphonuclear neutrophils by granulocytemacrophagge colony-stimulating factor is caused by inhibition of programmed cell-death. Blood 80:2920, 1992
60. Belloc F, Dumain P, Boisseau MR, Jalloustre C, Reiffers J, Bernard P, Lacombe F: A flow cylometric method using Hoechst 33342 and propidium iodide for simultaneous cell cycle analysis and apoptosis determination in unfixed cells. Cytometry 17:59, 1994
61. Park JR, Bernstein ID, Hockenberry DM: Primitive human hematopoietic precursors express Bcl-x but not Bcl-2. Blood 86:868, 1995